These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8981406)

  • 41. Early life stress causes refractoriness to haloperidol-induced catalepsy.
    Marrocco J; Mairesse J; Bucci D; Lionetto L; Battaglia G; Consolazione M; Ravasi L; Simmaco M; Morley-Fletcher S; Maccari S; Nicoletti F
    Mol Pharmacol; 2013 Aug; 84(2):244-51. PubMed ID: 23716620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
    Sevak RJ; Koek W; France CP
    Eur J Pharmacol; 2005 Jul; 517(1-2):64-7. PubMed ID: 15975572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The neostriatal inhibition of catalepsy, but not of muscle rigidity, evoked from the substantia nigra pars reticulata.
    Kolasiewicz W; Cools A; Ossowska K; Wolfarth S
    Pharmacol Biochem Behav; 1987 Dec; 28(4):453-7. PubMed ID: 3432312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical evidence for the involvement of gonadotropin releasing hormone in neuroleptic and cataleptic effects of haloperidol in mice.
    Fegade HA; Umathe SN
    Neuropeptides; 2016 Apr; 56():89-96. PubMed ID: 26706182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.
    Frussa-Filho R; Otoboni JR; Uema FT; Palermo-Neto J
    Braz J Med Biol Res; 1992; 25(9):925-8. PubMed ID: 1342840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
    Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
    Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats.
    Ellenbroek B; Schwarz M; Sontag KH; Jaspers R; Cools A
    Brain Res; 1985 Oct; 345(1):132-40. PubMed ID: 2998546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
    Umathe SN; Wanjari MM; Manna SS; Jain NS
    Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
    Erkent U; Iskit AB; Onur R; Ilhan M
    Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol.
    Jain NS; Tandi L; Verma L
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):59-66. PubMed ID: 26455279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological characteristics of zolpidem-induced catalepsy in the rat.
    Mierzejewski P; Kolaczkowski M; Nowak N; Korkosz A; Scinska A; Sienkiewicz-Jarosz H; Samochowiec J; Kostowski W; Bienkowski P
    Neurosci Lett; 2013 Nov; 556():99-103. PubMed ID: 24135337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the dopamine system in rat amygdala attenuates the picrotoxin-induced locomoter hyperactivity and hypertension.
    Chang CK; Wang NL; Lin MT
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):284-8. PubMed ID: 15191399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance to catalepsy following chronic haloperidol is not associated with changes in GABA release in the globus pallidus.
    O'Connor WT; Osborne PG; Ungerstedt U
    Brain Res; 1998 Mar; 787(2):299-303. PubMed ID: 9518659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Globus pallidus lesions inhibit the induction of c-Fos by haloperidol in the basal ganglia output nuclei in rats.
    Miwa H; Nishi K; Fuwa T; Mizuno Y
    Neurosci Lett; 1998 Jun; 250(1):29-32. PubMed ID: 9696058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neuroendocrine modulation of haloperidol-induced catalepsy].
    Speciale C; Ferrara N; Sortino MA; Giammona G; Bernardini R; De Simone D; Marano P
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):51-7. PubMed ID: 6303368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
    Jaskiw GE; Bongiovanni R
    Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.